Brief: Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology
26/08/2025 13:04
Aug 26 (Reuters) - Lucid Diagnostics Inc LUCD.O: PAVMED SIGNS LETTER OF INTENT TO LICENSE GROUNDBREAKING ENDOSCOPIC ESOPHAGEAL IMAGING TECHNOLOGY PAVMED INC - LUCID DIAGNOSTICS TO PARTNER WITH PAVMED ON TECHNOLOGY PAVMED INC - EXECUTES NON-BINDING LETTER WITH DUKE UNIVERSITY FOR TECHNOLOGY Source text: ID:nPn7xZKWma Further company coverage: LUCD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucid Diagnostics
See all newsBrief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
Lucid Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Lucid Diagnostics Inc expected to post a loss of 7 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks
U.S. STOCKS ON THE MOVE- American Airlines, Pot stocks, Paramount Skydance